| |||||||||||
CYPRESS SEMICONDUCTOR CORPORATION | |||||||||||
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (a) | |||||||||||
(In thousands, except per-share data) | |||||||||||
(Unaudited) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended | ||||||||||
|
June 28, |
|
% of |
|
March 29, |
|
% of |
|
June 29, |
|
% of |
|
2015 |
|
Revenue |
|
2015 |
|
Revenue |
|
2014 |
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Revenues |
$ 484,778 |
|
|
|
$ 209,137 |
|
|
|
$ 183,601 |
|
|
Revenue from intellectual property license (b) |
6,250 |
|
|
|
- |
|
|
|
- |
|
|
Non-GAAP Revenues |
$ 491,028 |
|
|
|
$ 209,137 |
|
|
|
$ 183,601 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP gross margin (loss) |
$ 138,073 |
|
28.5% |
|
$ (35,652) |
|
-17.0% |
|
$ 95,370 |
|
51.9% |
Stock-based compensation expense |
3,802 |
|
0.8% |
|
4,219 |
|
2.0% |
|
4,433 |
|
2.4% |
Ramtron acquisition costs and related amortization |
- |
|
0.0% |
|
- |
|
0.0% |
|
(109) |
|
-0.1% |
Changes in value of deferred compensation plan |
46 |
|
0.0% |
|
189 |
|
0.1% |
|
248 |
|
0.1% |
Impairment of assets, restructuring and other charges |
325 |
|
0.1% |
|
120 |
|
0.1% |
|
187 |
|
0.1% |
Effect of Non-GAAP revenue from intellectual property license |
6,250 |
|
0.7% |
|
- |
|
0.0% |
|
- |
|
0.0% |
Spansion merger costs and related amortization |
52,800 |
|
10.9% |
|
28,464 |
|
13.6% |
|
(925) |
|
-0.5% |
Non-GAAP gross margin (loss) |
$ 201,296 |
|
41.0% |
|
$ (2,660) |
|
-1.2% |
|
$ 99,204 |
|
53.9% |
|
|
|
|
|
|
|
|
|
|
|
|
GAAP research and development expenses |
$ 81,227 |
|
|
|
$ 50,522 |
|
|
|
$ 40,927 |
|
|
Stock-based compensation expense |
(7,007) |
|
|
|
(5,750) |
|
|
|
(4,362) |
|
|
Changes in value of deferred compensation plan |
(153) |
|
|
|
(617) |
|
|
|
(483) |
|
|
Impairment of assets, restructuring and other charges |
(96) |
|
|
|
(62) |
|
|
|
- |
|
|
Spansion merger costs and related amortization |
(827) |
|
|
|
(130) |
|
|
|
- |
|
|
Non-GAAP research and development expenses |
$ 73,144 |
|
|
|
$ 43,963 |
|
|
|
$ 36,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP selling, general and administrative expenses |
$ 86,011 |
|
|
|
$ 76,450 |
|
|
|
$ 42,059 |
|
|
Stock-based compensation expense |
(16,859) |
|
|
|
(8,827) |
|
|
|
(5,523) |
|
|
Ramtron acquisition costs and related amortization |
- |
|
|
|
- |
|
|
|
(385) |
|
|
Changes in value of deferred compensation plan |
(276) |
|
|
|
(1,110) |
|
|
|
(1,097) |
|
|
Impairment of assets, restructuring and other charges |
(36) |
|
|
|
- |
|
|
|
(877) |
|
|
Legal and other |
- |
|
|
|
(654) |
|
|
|
- |
|
|
Spansion merger costs and related amortization |
(1,634) |
|
|
|
(25,580) |
|
|
|
- |
|
|
Non-GAAP selling, general and administrative expenses |
$ 67,206 |
|
|
|
$ 40,279 |
|
|
|
$ 34,177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating income (loss) |
$ (80,962) |
|
|
|
$ (245,736) |
|
|
|
$ 10,584 |
|
|
Stock-based compensation expense |
27,667 |
|
|
|
18,797 |
|
|
|
14,318 |
|
|
Ramtron acquisition costs and related amortization |
1,305 |
|
|
|
1,305 |
|
|
|
2,077 |
|
|
Changes in value of deferred compensation plan |
474 |
|
|
|
1,916 |
|
|
|
1,828 |
|
|
Impairment of assets, restructuring and other charges |
- |
|
|
|
182 |
|
|
|
138 |
|
|
Legal and other |
458 |
|
|
|
654 |
|
|
|
- |
|
|
Effect of Non-GAAP revenue from intellectual property license |
6,250 |
|
|
|
- |
|
|
|
- |
|
|
Spansion merger costs and related amortization |
105,754 |
|
|
|
135,982 |
|
|
|
- |
|
|
Non-GAAP operating income (loss) |
$ 60,946 |
|
|
|
$ (86,900) |
|
|
|
$ 28,945 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP pretax profit (loss) |
(87,756) |
|
-18.1% |
|
$ (251,444) |
|
-120.2% |
|
$ 9,456 |
|
5.2% |
Stock-based compensation expense |
27,667 |
|
5.7% |
|
18,797 |
|
9.0% |
|
14,318 |
|
7.8% |
Ramtron acquisition costs and related amortization |
1,305 |
|
0.3% |
|
1,305 |
|
0.6% |
|
2,076 |
|
1.1% |
Changes in value of deferred compensation plan |
(54) |
|
0.0% |
|
1,241 |
|
0.6% |
|
75 |
|
0.0% |
Impairment of assets, restructuring and other charges |
- |
|
0.0% |
|
455 |
|
0.2% |
|
1,080 |
|
0.6% |
Legal and other |
458 |
|
0.1% |
|
654 |
|
0.3% |
|
- |
|
0.0% |
Effect of Non-GAAP revenue from intellectual property license |
6,250 |
|
1.1% |
|
- |
|
0.0% |
|
- |
|
0.0% |
Investment related losses (gains) |
(1,670) |
|
-0.3% |
|
2,728 |
|
1.3% |
|
1,367 |
|
0.7% |
Tax related, interest income, interest expense and other expenses |
2,586 |
|
0.5% |
|
869 |
|
0.4% |
|
(925) |
|
-0.5% |
Losses from equity method investment |
1,459 |
|
0.3% |
|
1,559 |
|
0.7% |
|
- |
|
0.0% |
Spansion merger costs and related amortization |
105,754 |
|
21.8% |
|
135,982 |
|
65.0% |
|
- |
|
- |
Non-GAAP pretax profit (loss) |
$ 55,999 |
|
11.4% |
|
$ (87,854) |
|
-42.1% |
|
$ 27,447 |
|
14.9% |
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) attributable to Cypress |
$ (90,051) |
|
|
|
$ (246,798) |
|
|
|
$ 9,527 |
|
|
Stock-based compensation expense |
27,667 |
|
|
|
18,797 |
|
|
|
14,318 |
|
|
Ramtron acquisition costs and related amortization |
1,305 |
|
|
|
1,305 |
|
|
|
2,075 |
|
|
Changes in value of deferred compensation plan |
(53) |
|
|
|
1,241 |
|
|
|
75 |
|
|
Impairment of assets, restructuring and other charges |
- |
|
|
|
455 |
|
|
|
1,080 |
|
|
Legal and other |
458 |
|
|
|
654 |
|
|
|
- |
|
|
Effect of Non-GAAP revenue from intellectual property license |
6,250 |
|
|
|
- |
|
|
|
- |
|
|
Investment related losses (gains) |
(1,670) |
|
|
|
2,728 |
|
|
|
1,367 |
|
|
Tax related, interest income, interest expense and other expenses |
1,751 |
|
|
|
(3,829) |
|
|
|
(1,719) |
|
|
Losses from equity method investment |
1,459 |
|
|
|
1,559 |
|
|
|
- |
|
|
Spansion merger costs and related amortization |
105,754 |
|
|
|
135,982 |
|
|
|
- |
|
|
Non-GAAP net income (loss) attributable to Cypress |
$ 52,870 |
|
|
|
$ (87,906) |
|
|
|
$ 26,723 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) per share attributable to Cypress - diluted |
$ (0.27) |
|
|
|
$ (1.26) |
|
|
|
$ 0.06 |
|
|
Stock-based compensation expense |
0.08 |
|
|
|
0.10 |
|
|
|
0.09 |
|
|
Ramtron acquisition costs and related amortization |
- |
|
|
|
0.01 |
|
|
|
0.01 |
|
|
Changes in value of deferred compensation plan |
- |
|
|
|
0.01 |
|
|
|
- |
|
|
Impairment of assets, restructuring and other charges |
- |
|
|
|
- |
|
|
|
0.01 |
|
|
Effect of Non-GAAP revenue from intellectual property license |
0.02 |
|
|
|
|
|
|
|
|
|
|
Investment related losses (gains) |
(0.01) |
|
|
|
0.01 |
|
|
|
0.01 |
|
|
Tax related, interest income, interest expense and other expenses |
0.01 |
|
|
|
(0.02) |
|
|
|
(0.01) |
|
|
Losses from equity method investment |
- |
|
|
|
0.01 |
|
|
|
- |
|
|
Non-GAAP share count adjustment |
- |
|
|
|
- |
|
|
|
(0.01) |
|
|
Spansion merger costs and related amortization |
0.32 |
|
|
|
0.69 |
|
|
|
- |
|
|
Non-GAAP net income (loss) per share attributable to Cypress - diluted |
$ 0.15 |
|
|
|
$ (0.45) |
|
|
|
$ 0.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Refer to the accompanying "Notes to Non-GAAP Financial Measures" for a detailed discussion of management's use of non-GAAP financial measures. | |||||||||||
(b) Non-GAAP revenue includes $6.25 million of Samsung intellectual property licensing revenue, not included in GAAP revenue as a result of the effects of purchase accounting for the Spansion merger. | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|